Based on the Global Fund Board’s decision in November 2022 on the funding available for the 2023- 2025 allocation period, Rwanda has been allocated US$172,114,507 for HIV, tuberculosis (TB), malaria and building resilient and sustainable systems for health (RSSH).3 The allocation amounts for all countries have been determined according to a methodology approved by the Global Fund Board, primarily based on disease burden and income level. Rwanda is classified as a lowincome country.